Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria

Salazar MR, Carbajal HA, Espeche WG, Aizpurua M, Leiva Sisnieguez CE, March CE, Balbin E, Stavile RN, Reaven GM. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria. J Intern Med. 2013; 273(6): 595–601.